openPR Logo
Press release

Bile Duct Cancer Market to Advance at a Significant Growth Rate During the Forecast Period (2019-32) - Estimates DelveInsight | Key Companies - AstraZeneca, Basilea Pharmaceutica, Eisai, TransThera Sciences (Nanjing), Incyte, Roche, Taiho Oncology, and ot

05-10-2022 01:21 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Bile Duct Cancer Market

Bile Duct Cancer Market

DelveInsight's "Bile Duct Cancer Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Bile Duct Cancer Market Size and Share in the 7MM (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Bile Duct Cancer market report covers emerging drugs, treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.

Bile Duct Cancer: An Overview
Bile duct cancer, also called cholangiocarcinoma, is a type of adenocarcinoma, which is cancer that starts in gland cells. Cholangiocarcinomas start in the gland cells that line the inside of the ducts.

CCA is a rare and heterogeneous malignant neoplasm with epithelial cell origin in the biliary duct. The major function of the bile duct is to move a fluid called bile from the liver and gallbladder to the small intestine, where it helps digest the fats in food.

Bile Duct Cancer Market Key Facts
In 2021, out of the total incident cases of Bile Duct Cancer (CCA), around 10,046 cases were Intrahepatic and 7,782 were Extrahepatic CCA respectively, in 7MM.
In 2021, the incident cases of Bile Duct Cancer (CCA) in Japan were found to be 4,470 among which total ICCA cases were 2,414 and total ECCA cases were 2056.
The United States showed the highest incident cases of ICCA, as compared to EU5, and Japan. As per the estimates, the total ICCA cases in the US were estimated to be 3700+ in 2021.
As per DelveInsight analysts, the total incident population of Bile Duct Cancer (CCA) in the US was estimated to be 5,600+ in 2021.
Among the European five countries, Germany had the highest incident population of Bile Duct Cancer (CCA) with 2,600+ cases, followed by Italy and the United Kingdom, which had an incident population of 2,000+ and 1,400+ respectively in 2021. On the other hand, Spain had the lowest incident population of 250+ cases in 2021.

Find a sample copy of the Bile Duct Cancer Market report at:
https://www.delveinsight.com/sample-request/bile-duct-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Bile Duct Cancer Market
As per DelveInsight, Bile Duct Cancer Market is expected to increase in the coming years owing to the growing incident population of CCA in the 7MM

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Bile Duct Cancer market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the Bile Duct Cancer market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Bile Duct Cancer Market Drivers
1. Rising Incidence
2. Increasing R&D Activities
3. Technological advancements in the identification of biomarkers

Request a sample and discover more about the report offerings @
https://www.delveinsight.com/report-store/bile-duct-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Bile Duct Cancer Epidemiology
The epidemiology section covers detailed insights into the historical and current Bile Duct Cancer patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032.

Bile Duct Cancer Epidemiology Segmentation
1. Incident Cases of Bile Duct Cancer
2. Age-specific Incident Cases of Bile Duct Cancer
3. Stage-specific Incident Cases of Bile Duct Cancer
4. Biomarker-specific Incident Cases of Bile Duct Cancer

Explore more about the Bile Duct Cancer Epidemiology @
https://www.delveinsight.com/report-store/bile-duct-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Bile Duct Cancer Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Bile Duct Cancer market or expected to get launched in the market during the study period. The analysis covers Bile Duct Cancer market uptake by drugs, patient uptake by therapies, and sales of each drug.

Report's Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Bile Duct Cancer Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Request for a sample report to understand more about the Bile Duct Cancer pipeline development activities @
https://www.delveinsight.com/report-store/bile-duct-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Bile Duct Cancer Therapeutics Assessment
Companies across the globe are diligently working toward the development of novel treatment therapies with a considerable amount of success over the years.

Globally, some of the key companies in the Bile Duct Cancer Market include AstraZeneca, Basilea Pharmaceutica, Eisai Pharmaceuticals, TransThera Sciences (Nanjing), Inc., Incyte Corporation, Roche, Taiho Oncology, and others.

Some of the key therapies in the Bile Duct Cancer Therapeutics landscape include Imfinzi (durvalumab), Derazantinib, E7090, TAS-120 (futibatinib), TT-0040, and others.

Learn more about the emerging therapies & key companies in the Bile Duct Cancer Therapeutics Market @
https://www.delveinsight.com/report-store/bile-duct-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Bile Duct Cancer Competitive Intelligence Analysis
4. Bile Duct Cancer Market Overview at a Glance
5. Bile Duct Cancer Disease Background and Overview
6. Bile Duct Cancer Patient Journey
7. Bile Duct Cancer Epidemiology and Patient Population
8. Bile Duct Cancer Treatment Algorithm, Current Treatment, and Medical Practices
9. Bile Duct Cancer Unmet Needs
10. Key Endpoints of Bile Duct Cancer Treatment
11. Bile Duct Cancer Marketed Products
12. Bile Duct Cancer Emerging Therapies
13. Bile Duct Cancer Seven Major Market Analysis
14. Attribute Analysis
15. Bile Duct Cancer Market Outlook (7 major markets)
16. Bile Duct Cancer Access and Reimbursement Overview
17. KOL Views on the Bile Duct Cancer Market.
18. Bile Duct Cancer Market Drivers
19. Bile Duct Cancer Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer

Get the Detailed TOC of the Bile Duct Cancer Market report here:
https://www.delveinsight.com/sample-request/bile-duct-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

Contact Us
Shruti Thakur
info@delveinsight.com
+1(919)321-6187
www.delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

DelveInsight is a leading Life Science market research and business consulting company recognised for its off-the-shelf syndicated market research reports as well as customised solutions to firms in the healthcare sector.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bile Duct Cancer Market to Advance at a Significant Growth Rate During the Forecast Period (2019-32) - Estimates DelveInsight | Key Companies - AstraZeneca, Basilea Pharmaceutica, Eisai, TransThera Sciences (Nanjing), Incyte, Roche, Taiho Oncology, and ot here

News-ID: 2620775 • Views:

More Releases from DelveInsight Business Research

Spasticity Clinical Pipeline 2025: A Comprehensive Review of 12+ Emerging Therapies from 10+ key Players, says DelveInsight
Spasticity Clinical Pipeline 2025: A Comprehensive Review of 12+ Emerging Therap …
According to DelveInsight's latest analysis, the global Spasticity pipeline features more than 10 active pharmaceutical companies that are advancing over 12 investigational therapies. The report offers a detailed evaluation of clinical trials, mechanisms of action, therapeutic approaches, routes of administration, and major developmental activities shaping the Spasticity treatment landscape. DelveInsight's report, "Spasticity Pipeline Insight, 2025," delivers an extensive overview of the current clinical development environment and the future outlook for the
Real-World Evidence Solution Market is set to grow at a 8.07% CAGR, reaching USD 5.2 billion by 2032, analyses DelveInsight
Real-World Evidence Solution Market is set to grow at a 8.07% CAGR, reaching USD …
According to DelveInsight, the real-world evidence (RWE) solutions market is expanding rapidly, primarily due to the increasing global burden of chronic diseases and the growing need to improve healthcare outcomes. In addition, advancements in big data analytics, artificial intelligence, and machine learning are enhancing the ability to efficiently process and interpret large-scale real-world datasets. The rising adoption of RWE solutions by pharmaceutical and biotechnology companies - to support drug development,
Spinal Implants Market is set to grow at a 5.50% CAGR, reaching USD 21.9 billion by 2032, analyses DelveInsight
Spinal Implants Market is set to grow at a 5.50% CAGR, reaching USD 21.9 billion …
According to DelveInsight's assessment, the rising burden of spinal disorders particularly within the growing elderly population - continues to significantly increase the demand for surgical correction procedures. Alongside this, the surge in sports-related injuries and trauma cases is accelerating the need for advanced implantable spinal solutions. There is also a notable shift toward non-fusion and motion-preserving devices that support spinal flexibility and enhance patient outcomes, especially for younger and more
Vascular Stents Market is set to grow at a 6.65% CAGR, reaching USD 18.28 billion by 2032, analyses DelveInsight
Vascular Stents Market is set to grow at a 6.65% CAGR, reaching USD 18.28 billio …
According to DelveInsight's assessment, the rising global burden of cancer is significantly increasing the demand for advanced treatment approaches such as tumor ablation. Minimally invasive ablation techniques are gaining strong traction due to their advantages, including faster recovery times, lower complication risks, and reduced costs compared with traditional surgical procedures. At the same time, continuous improvements in ablation technologies - particularly in radiofrequency, microwave, and cryoablation systems - have enhanced

All 5 Releases


More Releases for Bile

Global Bile Acid Market Outlook Report 2025
On Aug 22, Global Info Research released "Global Bile Acid Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report includes an overview of the development of the Bile Acid industry chain, the market status of Bile Acid Market, and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Bile Acid. According to our (Global Info Research) latest
Bile Duct Cancer Market Outlook: Diagnosis, Therapies, and Innovations
Bile Duct Cancer Market report, published by DataM Intelligence, delivers detailed insights and analysis on major market trends, growth prospects, and emerging challenges. With a strong focus on providing actionable intelligence, DataM Intelligence enables businesses to make well-informed decisions and maintain a competitive edge. By blending both qualitative and quantitative research approaches, the company offers thorough reports that support clients in navigating complex market environments, driving strategic expansion, and capitalizing
OX Bile Extract Market: Competitive Dynamics & Global Outlook 2024
LP INFORMATION offers a latest published report on OX Bile Extract Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the OX Bile Extract market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019.
Bile Duct Cancer Drugs and Companies Research 2023
Report Description This report analyzes the bile duct cancer market by type (intrahepatic, extrahepatic), diagnosis (blood tests, abdominal imaging, surgery), by treatment (chemotherapy, radiotherapy), by end user (hospital& clinics, academic institutes); it also studies the top manufacturers in the market. The bile duct cancer market is expected to grow at a CAGR of near about 9.2% during the forecast period. GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/3439013-bile-duct-cancer-market-research-report-global-forecast-till-2023 The major players in bile duct cancer
Bile Duct Cancer Market Overview and Report forecast 2025
Bile duct is a network of tube that connects the liver to the gall bladder. Bile duct carries a fluid called bile which is synthesize in the liver and stored in the gall bladder. The primary function of bile is breakdown of fats during digestion. Bile duct cancer is commonly known as cholangiocarcinoma. The particular cause of bile duct cancer is unknown but few factors that are responsible for developing
Bile Duct Cancer Market Size – Industry Share Report 2025
Bile duct is a network of tube that connects the liver to the gall bladder. Bile duct carries a fluid called bile which is synthesize in the liver and stored in the gall bladder. The primary function of bile is breakdown of fats during digestion. Bile duct cancer is commonly known as cholangiocarcinoma. The particular cause of bile duct cancer is unknown but few factors that are responsible for developing